← back to search

Sri V. V. Deevi

AstraZeneca (United Kingdom) · GB
Area of research
Genetics · Immunology
Research interest
Research interests include Genomics and Rare Diseases, Immunodeficiency and Autoimmune Disorders, Genetic Associations and Epidemiology, and Platelet Disorders and Treatments.
h-index
34
citations
5,670
works
53
NIH funding
primary concept
Biology
email

Recent publications

Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes.
2026cited by 0position: contributordoi
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes.
2026cited by 0position: contributordoi
Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis.
2025cited by 7position: contributordoi
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.
2024cited by 37position: contributordoi
GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements
Nature Communications 2022cited by 45position: middledoi
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Nature 2021cited by 589position: middledoi
Rare variant contribution to human disease in 281,104 UK Biobank exomes.
2021cited by 471position: contributordoi
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.
2021cited by 47position: contributordoi
Whole-genome sequencing of patients with rare diseases in a national health system
Nature 2020cited by 577position: middledoi
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature 2020cited by 239position: middledoi
Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
2020cited by 173position: contributordoi
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
Blood 2020cited by 60position: middledoi
Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome Sequencing.
2020cited by 52position: contributordoi
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature 2020cited by 6position: middledoi
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
2020cited by 5position: contributordoi
Surveying the contribution of rare variants to the genetic architecture of human disease through exome sequencing of 177,882 UK Biobank participants
2020cited by 1position: contributordoi
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders
Blood 2019cited by 217position: middledoi
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.
2019cited by 168position: contributordoi
Next‐generation sequencing for the diagnosis of<i>MYH9</i>‐RD: Predicting pathogenic variants
Human Mutation 2019cited by 41position: middledoi
How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel study.
2019cited by 33position: contributordoi
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
The American Journal of Human Genetics 2018cited by 72position: middledoi
Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield
Genetics in Medicine 2018cited by 63position: middledoi
Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency
Journal of Allergy and Clinical Immunology 2018cited by 38position: middledoi
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
The American Journal of Human Genetics 2016cited by 480position: middledoi
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders
Blood 2016cited by 184position: middledoi
A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
Science Translational Medicine 2016cited by 143position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2019–2026)Slavé Petrovski · Discovery Centre7 papers (2020–2026) · 7 papers (2020–2026) · 6 papers (2020–2026)Keren Carss · AstraZeneca (United Kingdom)6 papers (2020–2026)Katherine R. Smith · University Hospitals Bristol and Weston NHS Foundation Trust4 papers (2024–2026) · 4 papers (2020–2024)Adam Platt · AstraZeneca (United Kingdom)4 papers (2020–2024)Andrew R. Harper · AstraZeneca (Poland)3 papers (2020–2025)Karyn Megy · AstraZeneca (Sweden)3 papers (2019–2024) · 3 papers (2020–2021) · 3 papers (2020–2024) · 3 papers (2020–2024)Jonathan Mitchell · University of Miami3 papers (2025–2026)Margarete A. Fabre · AstraZeneca (Brazil)2 papers (2026–2026)Qiang Wu · Middle Tennessee State University2 papers (2026–2026)Erin Oerton · AstraZeneca (Sweden)2 papers (2026–2026)Dirk S. Paul · Cambridge University Health Partners2 papers (2021–2024)Eleanor Wheeler · AstraZeneca (United States)2 papers (2026–2026)Stewart MacArthur · AstraZeneca (United Kingdom)2 papers (2026–2026)